Filing Details
- Accession Number:
- 0001127602-23-027415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-15 09:23:16
- Reporting Period:
- 2023-11-14
- Accepted Time:
- 2023-11-15 09:23:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-14 | 5,620 | $178.05 | 202,643 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,328 | Indirect | 2021 GRAT |
Common Stock | 11,000 | Indirect | 2022 GRAT |
Common Stock | 20,000 | Indirect | 2023 GRAT |
Common Stock | 340 | Indirect | By Trust |
Common Stock | 750 | Indirect | By Trust |
Common Stock | 2,250 | Indirect | By Trust |
Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $177.99 to $178.11. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.